Effect of TrueTear Corneal Surface Imaging

Completed · Not applicable

Conditions studied: Cataract, Myopia

In brief

This study will evaluate the utility of TrueTear™ to improve anterior corneal surface imaging quality before cataract surgery, refractive lens exchange, or laser refractive surgery.

Key facts

Study ID

NCT03637348

Run by

Price Vision Group

People needed

45

Starts

2018-08-13

Expected to finish

2019-07-08

Last updated by the study team

2020-08-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Scheduled to undergo routine imaging for cataract surgery, refractive lens exchange or laser refractive surgery

You may not qualify if…

• A cardiac pacemaker, implanted or wearable defibrillator, or other implanted metallic or electronic device (e.g. cochlear implant) in the head or neck
• Chronic or frequent nosebleeds, a bleeding disorder (e.g. hemophilia), or another condition that can lead to increased bleeding
• A known hypersensitivity (allergy) to the hydrogel material that comes into contact with the inside of the nose during use of the TrueTearTM device
• Pregnancy
• Presence of any ocular disease or condition which in the investigator's opinion would confound the study results

Where it is running

• Price Vision Group — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.